Price target
37.940.00 0.00%
The 18 analysts offering 1 year price forecasts for GH have a max estimate of — and a min estimate of —.
Analyst rating
Based on 23 analysts giving stock ratings to GH in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GH EPS for the last quarter is −1.58 USD despite the estimation of −0.86 USD. In the next quarter EPS is expected to reach −0.87 USD. Track more of Guardant Health, Inc. financials and stay on top of what is up with the company.
In the next quarter Guardant Health, Inc. revenue is expected to reach 150.11 M USD. Check out Guardant Health, Inc. revenue and earnings and make informed decisions.
According to analysts, GH price target is 37.94 USD with a max estimate of 50.00 USD and a min estimate of 27.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with GH news and stock market news.
We've gathered opinions of 23 analysts rating GH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.